Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-092-5 | CAS number: 7786-17-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 18 March 1957 - 27 December 1957
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study pre-dates GLP and the standard guidelines; nevertheless, data is well reported and the experiment is conducted in accordance with generally accepted scientific principles.
- Qualifier:
- according to guideline
- Guideline:
- other: According to the method of Draize as cited in the Food-Drug-Cosmetic Law Journal, 10, 679, (1955).
- Deviations:
- no
- GLP compliance:
- no
- Type of study:
- Draize test
- Species:
- guinea pig
- Strain:
- other: Albino
- Sex:
- not specified
- Details on test animals and environmental conditions:
- - Age at study initiation: Young adult.
- Route:
- intradermal
- Vehicle:
- other: Saline
- Concentration / amount:
- 0.1 percent dilution in saline.
- Route:
- intradermal
- Vehicle:
- other: Saline
- Concentration / amount:
- 0.1 percent dilution in saline.
- No. of animals per dose:
- 10
- Details on study design:
- The animals were depilated over a dorsal area of approximately 7 x 10 cm.
The test sample was prepared as a 0.1 percent dilution in saline and injected intracutaneously according to the following schedule:
- An initial does of 0.05 mL was followed by nine successive injections of 0.1 mL on alternate weekdays.
- The 10 induction doses were followed by a 14 day rest interval in which no test material was administered.
- After the interval, a single challenge dose of 0.05 mL was administered.
The various injection sites were scattered over the depilated area (which was kept free of hair by repeated clipping with an electric clipper) and records were kept of the location of each injection.
Reactions at each site were scored in terms of the diameter and height of the wheals (in mm) and the intensity of erythema (on a scale of 0 to 4 for increasing intensity).
No erythema 0
Very slight erythema (barely perceptible) 1
Well-defined erythema 2
Moderate to severe erythema 3
Severe erythema (beet redness) or eschar formation (injuries in depth) preventing erythema reading 4 - Reading:
- other: Maximum induction reading
- Group:
- test chemical
- Dose level:
- 0.1 mL
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- The positive results seen were signs of irritation
- Remarks on result:
- other: Reading: other: Maximum induction reading. Group: test group. Dose level: 0.1 mL. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: The positive results seen were signs of irritation.
- Reading:
- other: Maximum challenge reading
- Group:
- test chemical
- Dose level:
- 0.05 mL
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Clinical observations:
- The positive results seen were signs of irritation
- Remarks on result:
- other: Reading: other: Maximum challenge reading. Group: test group. Dose level: 0.05 mL. No with. + reactions: 9.0. Total no. in groups: 10.0. Clinical observations: The positive results seen were signs of irritation.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The skin sensitisation test conducted in the guinea pig showed the test material to be irritating under the conditions of the study but did not induce sensitisation.
- Executive summary:
A skin sensitisation study was carried out to assess the potential of the test material to induce a sensitising reaction in the albino guinea pig. The study was carried out according to the method of Draize, as published in the Food-Drug-Cosmetic Law Journal, 10, 679, (1955).
The test material was administered as a 0.1 % dilution and injected intracutaneously. An initial dose of 0.05 mL was followed by nine successive injections of 0.1 mL on alternate weekdays.
Following a rest interval of two weeks, a single challenge dose of 0.05 mL was administered.
The skin reactions were scored on the height and depth of any wheals formed and the intensity of any erythema seen (on a scale of 0 to 4 for increasing intensity)
It was seen that the induction intracutaneous injections produced moderate degrees of irritation. However the challenge injections produced less severe reactions. Therefore this test showed the test material to be slightly irritating under the conditions of the study but did not induce sensitisation.
Reference
Table 1 Skin Reactions in Sensitisation Test
Guinea pig Number |
Maximum Scores* |
|||||
Induction Sites |
Challenge Dose Site |
|||||
Diameter of wheal (mm) |
Height of wheal (mm) |
Degree of Erythema† |
Diameter of wheal (mm) |
Height of wheal (mm) |
Degree of Erythema† |
|
1 2 3 4 5 6 7 8 9 10 |
7 7 8 8 8 8 7 7 8 5 |
1 1 1 1 1 1 1 1 1 1 |
1 1 1 1 1 1 1 1 1 1 |
4 4 3 3 6 5 4 4 5 0 |
0 0 0 0 0 1 1 1 1 0 |
1 1 1 1 1 1 1 1 1 0 |
Average |
7.3 |
1.0 |
1.0 |
3.8 |
0.4 |
0.9 |
*Scored according to Draize
†Scale of 0 to 4 for increasing intensity
The intracutaneous injections of the test material produced moderate degrees of irritation. The first sign of irritation developed at the third or fourth injection in most cases and was then apparent in all subsequent doses.
However, the challenge injections produced less severe reactions than the induction doses with none of the challenge sites flaring up as a result of the challenge injections.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In the key study, the potential of the test material to induce a sensitising reaction in the albino guinea pig was assessed in accordance with the method of Draize, as published in the Food-Drug-Cosmetic Law Journal,10, 679, (1955). The study was performed to a good standard with a sufficient level of reporting to assess the quality of the submitted data, accordingly the study was assigned a reliability score of 2 in line with Klimisch (1997).
The test material was administered as a 0.1 % dilution and injected intracutaneously. An initial dose of 0.05 mL was followed by nine successive injections of 0.1 mL on alternate weekdays.
Following a rest interval of two weeks, a single challenge dose of 0.05 mL was administered.
The skin reactions were scored on the height and depth of any wheals formed and the intensity of any erythema seen (on a scale of 0 to 4 for increasing intensity)
It was seen that the induction intracutaneous injections produced moderate degrees of irritation. However the challenge injections produced less severe reactions. Therefore this test showed the test material to be slightly irritating under the conditions of the study but did not induce sensitisation.
The irritation observed in this study is in agreement with the findings presented for dermal irritation, where slight reactions were observed below the limits of classification.
Migrated from Short description of key information:
Non-sensitising, study conducted according to Draize 1955.
Justification for selection of skin sensitisation endpoint:
Study conducted in accordance with sound scientific principles, with a sufficient level of reporting to assess the quality of the data submitted. The study was assigned a reliability score of 2 in line with the principles set forth by Klimisch (1997).
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
According to the criteria outlined in Regulation (EC) No. 1272/2008 and Directive 67/548/EEC, this substance does not meet the criteria for classification as a skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.